(Q71572173)
Statements
High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial (English)
Schrier DM
Stemmer SM
Johnson T
Kasliwal R
Lear J
Matthes S
Taffs S
Dufton C
Glenn SD
1 December 1995